Skip to main content
  • Saved

made a Post

Uptake of Oncology Biosimilars: Managed Care Strategies to Improve Value-Based Care Systems

Uptake of Oncology Biosimilars: Managed Care Strategies to Improve Value-Based Care Systems

Source :

https://www.ajmc.com/view/uptake-of-oncology-biosimilars-managed-care-strategies-to-improve-value-based-care-systems

The use of biosimilars in oncology and as supportive agents for patients with cancer has introduced an important opportunity to expand access to cost-effective care, but their utilization remains inconsistent and is influenced by a variety of factors.


Conclusion: Real-world switch studies in oncology biosimilars that have demonstrated bioequivalence provide basis to support efficacy and safety to transition to a biosimilar product. Incorporating oncology biosimilars into treatment pathways will be an important next step in providing value-based care to patients with cancer.